ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Polycomb repressor complex-2 is a novel target for mesothelioma therapy.

Clinton D Kemp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.